|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
1,290,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
179,982 |
741,257 |
Total Sell Value |
$0 |
$0 |
$17,352,015 |
$61,177,025 |
Total People Sold |
0 |
0 |
5 |
8 |
Total Sell Transactions |
0 |
0 |
20 |
88 |
End Date |
2025-07-20 |
2025-04-18 |
2024-10-18 |
2023-10-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2025-09-08 |
4 |
D |
$32.41 |
$238,408 |
D/D |
(7,356) |
500,908 |
|
- |
|
Cowan Elvia |
SVP, FINANCE |
|
2025-09-08 |
4 |
D |
$32.41 |
$15,622 |
D/D |
(482) |
26,156 |
|
- |
|
Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
|
2025-09-08 |
4 |
D |
$32.41 |
$39,022 |
D/D |
(1,204) |
33,670 |
|
- |
|
Guggenhime Andrew |
PRESIDENT AND CFO |
|
2025-09-08 |
4 |
D |
$32.41 |
$93,665 |
D/D |
(2,890) |
124,309 |
|
- |
|
Wassil Jim |
CHIEF OPERATING OFFICER |
|
2025-09-08 |
4 |
D |
$32.41 |
$89,419 |
D/D |
(2,759) |
141,848 |
|
- |
|
Cowan Elvia |
SVP, FINANCE |
|
2025-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,810 |
27,205 |
|
- |
|
Wassil Jim |
CHIEF OPERATING OFFICER |
|
2025-09-02 |
4 |
D |
$31.56 |
$135,266 |
D/D |
(4,286) |
146,270 |
|
- |
|
Guggenhime Andrew |
PRESIDENT AND CFO |
|
2025-09-02 |
4 |
D |
$31.56 |
$160,325 |
D/D |
(5,080) |
127,199 |
|
- |
|
Cowan Elvia |
SVP, FINANCE |
|
2025-09-02 |
4 |
D |
$31.56 |
$17,895 |
D/D |
(567) |
26,638 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2025-09-02 |
4 |
D |
$31.56 |
$342,110 |
D/D |
(10,840) |
508,264 |
|
- |
|
Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
|
2025-09-02 |
4 |
D |
$31.56 |
$48,539 |
D/D |
(1,538) |
34,874 |
|
- |
|
Lukatch Heath |
Director |
|
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
17,216 |
|
- |
|
Loxam Teri |
Director |
|
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
10,216 |
|
- |
|
Paya Carlos V |
Director |
|
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
4,591 |
|
- |
|
Gilbert Halley E |
Director |
|
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
10,216 |
|
- |
|
Drapeau Anne S |
Director |
|
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
10,216 |
|
- |
|
Lee Jacks |
Director |
|
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
4,591 |
|
- |
|
Brandicourt Olivier |
Director |
|
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,148 |
1,148 |
|
- |
|
Furey John |
Director |
|
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
3,041 |
|
- |
|
Dhaliwal Harpreet S. |
Chief Technical Ops OfficerOff |
|
2025-04-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
36,083 |
|
- |
|
Lukatch Heath |
Director |
|
2025-04-08 |
4 |
OE |
$16.00 |
$117,490 |
D/D |
7,000 |
14,175 |
|
- |
|
Guggenhime Andrew |
PRESIDENT AND CFO |
|
2025-04-07 |
4 |
OE |
$20.93 |
$99,983 |
D/D |
4,777 |
131,950 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2025-04-04 |
4 |
OE |
$5.35 |
$183,888 |
D/D |
20,533 |
518,775 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2025-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
57,938 |
508,239 |
|
- |
|
Eydelman Mikhail |
SVP, GEN COUNSEL & CORP SEC |
|
2025-03-05 |
4 |
AS |
$70.39 |
$353,699 |
D/D |
(5,000) |
41,620 |
|
- |
|
504 Records found
|
|
Page 1 of 21 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|